The Grouse & Grape Luncheon 2018

The eighth annual Grouse & Grape Luncheon was held on Tuesday 9th October at the historic Spencer House, and attracted over 340 guests who helped raise £31,000 (net) for The Cure Parkinson's Trust.Read more

Type 2 Diabetes Linked to Higher Rate of Parkinson's

The study published in Neurology is the largest study to date on the link between the two conditions.Read more

CPT Featured in The Telegraph - 'Could we be on the brink of a Parkinson's breakthrough?'

There is a general feeling of positivity within the Parkinson's research community and this article captures this.Read more

Grand Challenges in Parkinson's 2018

'Grand Challenges in Parkinson’s Disease' brings together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s research. The 2018 theme was Non-Motor Symptoms.Read more

The Linked Clinical Trials Meeting 2018

The international Linked Clinical Trials committee met again in September for its annual assessment and evaluation of multiple drugs and compounds with the potential to modify Parkinson's. Find out more...Read more

Rallying to the Challenge 2018 – Facebook Live

Re-watch the Rallying to the Challenge Facebook Live panel discussion broadcast from this year's meeting at VARI with panellists discussing the theme of this year’s symposium – 'Non motor symptoms in Parkinson’s' touching on areas such as sleep, issues with sense of smell and the relationship of the gut to Parkinson’s.Read more

Dr Simon Stott joins The Cure Parkinson's Trust

The Cure Parkinson's Trust is delighted to welcome Dr Simon Stott as the newly appointed Deputy Director of Research. Simon joins the team on 1st October 2018.Read more

Webinar Discussion: “How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions, and Histology.”

Re-watch the second of our new quarterly webinar series in partnership with Parkinson’s Movement and the Journal of Parkinson’s Disease .Read more

Rapsodi Study

Rapsodi is an internet based cohort study designed to assess those with mutations in the GBA gene for the earliest signs of Parkinson’s disease. Its eventual aim is to provide a platform for targeting neuroprotective medication to those who are developing or at a high risk of developing Parkinson’s disease.Read more

Bonhams Hosts 'Cure3'- A Unique Selling Art Exhibition in Support of CPT

The Cure Parkinson’s Trust, in association with Bonhams and Artwise, is delighted to announce the second edition of Cure3, an acclaimed selling exhibition devised to raise awareness of and funds for Parkinson’s research.Read more

Denali Announce Positive LRRK2 Trial Results with Advance to Phase 1b Trial

Denali Therapeutics has announced positive clinical results from their LRRK2 inhibitor programme and their advance to a Phase 1b trial in Parkinson’s patients with and without a genetic LRRK2 mutation.Read more

Cure3 2018: Art for Parkinson's

We are delighted that Cure3 is taking place again this year! Over 80 leading artists and architects will create exclusive works which will be sold at this unique selling exhibition...Read more

Parkinson’s Movement Awarded Wellcome Public Engagement Fund Grant

The Cure Parkinson's Trust (CPT) is delighted that Parkinson's Movement (PM) has secured a Wellcome Public Engagement Fund grant from The Wellcome Trust which will support the development of audio/visual content on the PM website.Read more

Drug Repurposing in Parkinson's

Given the number of failures and the ever-increasing costs and lengthy processes for drug development, our attention continues to be focused on utilising existing compounds approved for other conditions as novel treatments for Parkinson’s...Read more

R S Macdonald Trust Awards Grant for Further Stem Cell Research

The Cure Parkinson’s Trust is delighted that the R S Macdonald Charitable Trust has awarded a grant to co-fund the continuing dopamine replacement stem cell research of Dr Tilo Kunath at the MRC in Edinburgh.Read more

Trial Design for Parkinson's Disease Modification

Helen Matthews, Deputy CEO, attended a recent summit in New York focused specifically on trial design for disease modification organised by The Michael J. Fox Foundation for Parkinson’s Research.Read more

Kyoto Team Begin Cell Replacement Trial In Parkinson's

Professor Jun Takahashi & colleagues at the University of Kyoto Japan have announced that they are to start the world’s first clinical trial of cells derived from induced pluripotent stem cells in people with Parkinsons...Read more

Cell Replacement Therapies for Parkinson's - Dr Tilo Kunath

Dr Tilo Kunath is working with cells derived from people with Parkinson's to understand the underlying causes of the condition; to test drugs that might treat it and to replace those cells which are lost.Read more

Stem Cell Therapies - Research Update

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.Read more

LRRK2 May Play a Role in Idiopathic Parkinson's

Abnormally increased kinase activity due to mutations in the leucine-rich repeat kinase 2 (LRRK2) gene is the cause of Parkinson’s in about 3 to 4% of people with Parkinson's however researchers have found that independent of any mutations, LRRK2 may also play a role in idiopathic Parkinson's.Read more

AMRC - Spotlight Report on Healthy Ageing

The AMRC's 'Spotlight Report on Healthy Ageing' is highlighting the work medical research charities are doing to prevent disease and promote health in the UK's ageing society...Read more